Related references
Note: Only part of the references are listed.A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstrom macroglobulinemia
Guang Yang et al.
BLOOD (2013)
MYD88 L265P mutation in Waldenstrom macroglobulinemia
Stephanie Poulain et al.
BLOOD (2013)
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms
Marzia Varettoni et al.
BLOOD (2013)
A new era for Waldenstrom macroglobulinemia: MYD88 L265P
Steven P. Treon et al.
BLOOD (2013)
MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
Lian Xu et al.
BLOOD (2013)
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas
N. Gachard et al.
LEUKEMIA (2013)
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia
C. Jimenez et al.
LEUKEMIA (2013)
MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia
Steven P. Treon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A20: linking a complex regulator of ubiquitylation to immunity and human disease
Averil Ma et al.
NATURE REVIEWS IMMUNOLOGY (2012)
High-Throughput Genomic Analysis in Waldenstrom's Macroglobulinemia
Stephanie Poulain et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Molecular cytogenetic analysis of Korean patients with Waldenstrom macroglobulinemia
Soo-Mee Bang et al.
CANCER GENETICS AND CYTOGENETICS (2010)
A20: from ubiquitin editing to tumour suppression
Sarah G. Hymowitz et al.
NATURE REVIEWS CANCER (2010)
Analysis of 6q deletion in Waldenstrom macroglobulinemia
Hong Chang et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia:: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals
N. C. Gutierrez et al.
LEUKEMIA (2007)
6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance
Roelandt F. J. Schop et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Characterization of familial Waldenstrom's macroglobulinemia
SP Treon et al.
ANNALS OF ONCOLOGY (2006)
Trisomy 4, a new chromosomal abnormality in Waldenstrom's macroglobulinemia: a study of 39 cases
C. Terre et al.
LEUKEMIA (2006)
XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation
AL Shaffer et al.
IMMUNITY (2004)
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia
RG Owen et al.
SEMINARS IN ONCOLOGY (2003)
Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions
RFJ Schop et al.
BLOOD (2002)
Share Paper
